Long-term persistence of cellular immunity to Oka vaccine virus induced by pernasal co-administration with Escherichia coli enterotoxin in mice

Vaccine
N KamiyaT Tsuji

Abstract

A mutant of Escherichia coli enterotoxin induced cellular immunity to a live varicella vaccine (the Oka strain) as a mucosal adjuvant in mice. The persistence of this cellular immunity was investigated. A commercially available live Oka vaccine virus and toxin were administered once simultaneously via the nasal route, in mice. Ten or 12 months later, a delayed-type hypersensitivity to the vaccine virus was detected by footpad test, but an antibody neutralizing the varicella-zoster virus was not. When spleen cells from mice immunized with the vaccine and toxin were re-stimulated by live vaccine in vitro, their thymidine uptake and IL-2 production were higher than those from mice immunized with the vaccine alone, but lower than those of spleen cells prepared from mice 2 months after nasal administration. Production of IL-4 in these cells, however, was not induced by re-stimulation in vitro. These results suggest that although humoral immunity for Oka vaccine virus is only weakly induced by one co-administration of the vaccine and toxin, cellular immunity is induced and maintained over 1 year, though it declines with age. The nasal administration of the vaccine and toxin might be effective for maintaining cellular immunity to the ...Continue Reading

References

Aug 1, 1992·The Journal of Infectious Diseases·A M Arvin
Aug 1, 1992·The Journal of Infectious Diseases·M G Myers, B L Connelly
Aug 1, 1992·The Journal of Infectious Diseases·A A GershonS Silverstein
Jan 1, 1988·Critical Reviews in Oncology/hematology·C Grose, R H Giller
Mar 1, 1987·Journal of Clinical Immunology·A R Hayward, M Herberger
Jun 1, 1980·American Journal of Diseases of Children·M DworskyC Alford
Jan 28, 1994·Cell·W E Paul, R A Seder
Mar 1, 1996·European Journal of Immunology·Y KawamotoA Miyama
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·J B SunC Czerkinsky
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·S YamamotoJ R McGhee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.